The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 09, 2022
Filed:
May. 27, 2016
Applicant:
Genentech, Inc., South San Francisco, CA (US);
Inventors:
Alice Elizabeth Guardino, South San Francisco, CA (US);
Meghna Samant, South San Francisco, CA (US);
Alexander Strasak, South San Francisco, CA (US);
Melanie Smitt, South San Francisco, CA (US);
Monika Patre, South San Francisco, CA (US);
Assignee:
Genentech, Inc., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 47/68 (2017.01); C07K 16/32 (2006.01); A61K 31/395 (2006.01); A61K 31/337 (2006.01); A61K 39/395 (2006.01); A61P 35/04 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6855 (2017.08); A61K 31/337 (2013.01); A61K 31/395 (2013.01); A61K 39/39558 (2013.01); A61K 47/6803 (2017.08); A61P 35/04 (2018.01); C07K 16/32 (2013.01); A61K 2039/507 (2013.01);
Abstract
Methods of treating patients having HER2-positive, locally advanced or previously untreated metastatic breast cancer having received prior treatment with a taxane using an anti-HER2-maytansinoid conjugate (for example trastuzumab emtansine) are provided.
Guardino, Alice. (2022). Methods of treating her2-positive metastatic breast cancer (U.S. Patent No. 11406715). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11406715
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile